Interleukin 17a anticorps
Aperçu rapide pour Interleukin 17a anticorps (ABIN6964028)
Antigène
Voir toutes Interleukin 17a (IL17A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Native and recombinant IL-17A.
-
Réactivité croisée (Details)
- The antibody cross-reacts with IL-17A from non-human primates. Cross-reactivity has been tested in ELISA and/or ELISpot.
-
Purification
- Purified from in vitro cultures by protein G affinity chromatography.
-
Immunogène
- Recombinant human IL-17A
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Neutralization of human IL-17A bioactivity. It is recommended to establish the optimal antibody concentration for the assay system used. The antibody is also suitable for immunoassays. Neutralization Neutralization assay: Neutralization of human IL-17A induced IL-6 production (see graph). To determine the neutralizing capacity and ND50, various concentrations of mAb MT504 and human recombinant IL-17A were added to normal human dermal fibroblasts. Following overnight incubation, cell supernatants were quantified in IL-6 ELISA. Neutralization dose 50 (ND50): MT504 neutralized the effect of IL-17A at a ND50value of 0.01-0.03 μg/mL when 10 ng/mL IL-17A was present. ND50 is defined as the concentration of antibody that results in 50 % inhibition of the biological response under the experimental conditions specified.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- supplied at 0.5 mg/mL in PBS free of preservatives
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/thawing.
-
Date de péremption
- 18 months
-
-
- Interleukin 17a (IL17A) (Interleukin 17A (IL17A))
-
Autre désignation
- IL17A
-
ID gène
- 3605
Antigène
-